Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling

Journal of Clinical Investigation

Volumn 101, Issue 4, 1998, Pages 731-736

  Rudic, Radu Daniel ^a   Shesely, Edward G ^c   Maeda, Nobuyo ^d   Smithies, Oliver ^d   Segal, Steven S ^b   Sessa, William C ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c HENRY FORD HOSPITAL   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Carotid artery; eNOS knockout mice; Hyperplasty; Nitric oxide; Proliferation

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATHEROSCLEROSIS; COMMON CAROTID ARTERY; GENE; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MORPHOMETRICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; THICKNESS; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

EID: 0032520153     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI1699     Document Type: Article

References (38)

1. Gibbons, G.H., and V.J. Dzau. 1994. The emerging concept of vascular remodeling. N. Engl. J. Med. 330:1431-1438.
2. Kamiya, A., and T. Togawa. 1980. Adaptive regulation of wall shear stress to flow change in the canine carotid artery. Am. J. Physiol. 239:H14-H21.
3. Langille, B.L., M.P. Bendeck, and F.W. Keeley. 1989. Adaptations of carotid arteries of young and mature rabbits to reduced carotid blood flow. Am. J. Physiol. 256:H931-H939.
4. Kohler, T.R., T.R. Kirkman, L.W. Kraiss, B.K. Zierler, and A.W. Clowes. 1991. Increased blood flow inhibits neointimal hyperplasia in endothelialized vascular grafts. Circ. Res. 69:1557-1565.
5. Davies, P.F. 1995. Flow-mediated endothelial mechanotransduction. Physiol. Rev. 75:519-560.
6. Langille, B.L., and F. O'Donnell. 1986. Reductions in arterial diameter produced by chronic decreases in blood flow are endothelium-dependent. Science. 231:405-407.
7. Kuchan, M.J., and J.A. Frangos, 1994. Role of calcium and calmodulin in flow-induced nitric oxide production in endothelial cells. Am. J. Physiol. 266: C628-C636.
8. Rubanyi, G.M., J.C. Romero, and P.M. Vanhoutte. 1986. Flow-induced release of endothelium-derived relaxing factor. Am. J. Physiol. 250:H1145-1149.
9. Uematsu, M., Y. Ohara, J.P. Navas, K. Nishida, T.J. Murphy, R.W. Alexander, R.M. Nerem, and D.G. Harrison. 1995. Regulation of endothelial cell nitric oxide synthase mRNA expression by shear stress. Am. J. Physiol. 269: C1371-1378.
10. Awolesi, M.A., W.C. Sessa, and B.E. Sumpio. 1995. Cyclic strain upregulates nitric oxide synthase in cultured bovine aortic endothelial cells. J. Clin. Invest. 96:1449-1454.
11. Sessa, W.C., K. Pritchard, N. Seyedi, J. Wang, and T.H. Hintze. 1994. Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ. Res. 74:349-353.
12. Palmer, R.M., A.G. Ferrige, and S. Moncada. 1987. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 327:524-526.
13. Ignarro, L.J., G.M. Buga, K.S. Wood, R.E. Byrns, and G. Chaudhuri. 1987. Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. USA. 84:9265-9269.
14. Garg, U.C., and A. Hassid. 1989. Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 83:1774-1777.
15. Cornwell, T.L., E. Arnold, N.J. Boerth, and T.M. Lincoln. 1994. Inhibition of smooth muscle cell growth by nitric oxide and activation of cAMP-dependent protein kinase by cGMP. Am. J. Physiol. 267:C1405-C1413.
16. Sarkar, R., E.G. Meinberg, J.C. Stanley, D. Gordon, and R.C. Webb. 1996. Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ. Res. 78:225-230.
17. von der Leyen, H.E., G.H. Gibbons, R. Morishita, N.P. Lewis, L. Zhang, M. Nakajima, Y. Kaneda, J.P. Cooke, and V.J. Dzau. 1995. Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene. Proc. Natl. Acad. Sci. USA. 92:1137-1141.
18. Noiri, E., Y. Hu, W.F. Bahou, C.R. Keese, I. Giaever, and M.S. Goligorsky. 1997. Permissive role of nitric oxide in endothelin-induced migration of endothelial cells. J. Biol. Chem. 272:1747-1752.
19. Papapetropoulos, A., K.M. Desai, R.D. Rudic, B. Mayer, R. Zhang, M.P. Ruiz-Torres, G. Garcia-Cardena, J.A. Madri, and W.C. Sessa. 1997. Nitric oxide synthase inhibitors attenuate transforming-growth-factor-beta 1-stimulated capillary organization in vitro. Am. J. Pathol. 150:1835-1844.
20. Ziche, M., L. Morbidelli, E. Masini, S. Amerini, H.J. Granger, C.A. Maggi, P. Geppetti, and F. Ledda. 1994. Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J. Clin. Invest. 94:2036-2044.
21. Murrell, G.A., D. Jang, and R.J. Williams. 1995. Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem. Biophys. Res. Commun. 206:15-21.
22. Trachtman, H., S. Futterweit, P. Garg, K. Reddy, and P.C. Singhal. 1996. Nitric oxide stimulates the activity of a 72-kDa neutral matrix metalloproteinase in cultured rat mesangial cells. Biochem. Biophys. Res. Commun. 218:704-708.
23. Tronc, F., M. Wassef, B. Esposito, D. Henrion, S. Glagov, and A. Tedgui. 1996. Role of NO in flow-induced remodeling of the rabbit common carotid artery. Arterioscler. Thromb. Vasc. Biol. 16:1256-1262.
24. Shesely, E.G., N. Maeda, H.S. Kim, K.M. Desai, J.H. Krege, V.E. Laubach, P.A. Sherman, W.C. Sessa, and O. Smithies. 1996. Elevated blood pressures in mice lacking endothelial nitric oxide synthase. Proc. Natl. Acad. Sci USA. 93:13176-13181.
25. Segal, S.S., D.T. Kurjiaka, and A.L. Caston. 1993. Endurance training increases arterial wall thickness in rats. J. Appl. Physiol. 74:722-726.
26. Guyton, J.R., and C.J. Hartley. 1985. Flow restriction of one carotid artery in juvenile rats inhibits growth of arterial diameter. Am. J. Physiol. 248: H540-H546.
27. Carmeliet, P., V. Ferreira, G. Breier, S. Pollefeyt, L. Kieckens, M. Gertsenstein, M. Fahrig, A. Vandenhoeck, K. Harpal, C. Eberhardt, C. Declercq, et al. 1996. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature. 380:435-439.
28. Suri, C., P.F. Jones, S. Patan, S. Bartunkova, P.C. Maisonpierre, S. Davis, T.N. Sato, and G.D. Yancopoulos. 1996. Requisite role of angiopoietin-1. a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell. 87: 1171-1180.
29. Carmeliet, P., L. Moons, V. Ploplis, E. Plow, and D. Collen. 1997. Impaired arterial neointima formation in mice with disruption of the plasminogen gene. J. Clin. Invest. 99:200-208.
30. Iafrati, M.D., R.H. Karas, M. Aronovitz, S. Kim, T.R. Sullivan, Jr., D.B. Lubahn, T.F. O'Donnell, Jr., K.S. Korach, and M.E. Mendelsohn. 1997. Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice. Nat. Med. 3:545-548.
31. Miyashiro, J.K., V. Poppa, and B.C. Berk. 1997. Flow-induced vascular remodeling in the rat carotid artery diminishes with age. Circ. Res. 81:311-319.
32. Numaguchi, K., K. Egashira, M. Takemoto, T. Kadokami, H. Shimokawa, K. Sueishi, and A. Takeshita. 1995. Chronic inhibition of nitric oxide synthesis causes coronary microvascular remodeling in rats. Hypertension (Dallas). 26:957-962.
33. Mondy, J.S., V. Lindner, J.K. Miyashiro, B.C. Berk, R.H. Dean, and R.L. Geary. 1997. Platelet-derived growth factor ligand and receptor expression in response to altered blood flow in vivo. Circ. Res. 81:320-327.
34. Lopez-Farre, A., L. Sanchez de Miguel, C. Caramelo, J. Gomez-Macias, R. Garcia, J.R. Mosquera, T. de Frutos, I. Millas, F. Rivas, G. Echezarreta, and S. Casado. 1997. Role of nitric oxide in autocrine control of growth and apoptosis of endothelial cells. Am. J. Physiol. 272:H760-H768.
35. Hansson, G.K., Y.J. Geng, J. Holm, P. Hardhammar, A. Wennmalm, and E. Jennische. 1994. Arterial smooth muscle cells express nitric oxide synthase in response to endothelial injury. J. Exp. Med. 180:733-738.
36. Van, Z.Q., T. Yokota, W. Zhang, and O.K. Hansson. 1996. Expression of inducible nitric oxide synthase inhibits platelet adhesion and restores blood flow in the injured artery. Circ: Res. 79:38-44.
37. Tzeng, E., L.L.N. Shears, P.D. Robbins, B.R. Pitt, D.A. Geller, S.C. Watkins, R.L. Simmons, and T.R. Billiar. 1996. Vascular gene transfer of the human inducible nitric oxide synthase: characterization of activity and effects on myointimal hyperplasia. Mol. Med. 2:211-225.
38. Garcia-Cardena, G., P. Oh, J. Liu. J.E. Schnitzer, and W.C. Sessa. 1996. Targeting of nitric oxide synthase to endothelial cell caveolae via palmitoylation: implications for nitric oxide signaling. Proc. Natl. Acad. Sci. USA. 93:6448-6453.